Faculty Opinions recommendation of Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.721227571.793511072 ◽

2015 ◽

Author(s):

WH Wilson Tang

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial

European Heart Journal ◽

10.1093/eurheartj/ehq502 ◽

2011 ◽

Vol 32 (7) ◽

pp. 820-828 ◽

Author(s):

B. Pitt ◽

S. D. Anker ◽

D. A. Bushinsky ◽

D. W. Kitzman ◽

F. Zannad ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure

Journal of the American College of Cardiology ◽

10.1016/0735-1097(93)90816-j ◽

1993 ◽

Vol 22 (1) ◽

pp. 65-72 ◽

Author(s):

Milton Packer ◽

◽

Kenneth A. Narahara ◽

Uri Elkayam ◽

Jay M. Sullivan ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Rationale and design of the DIGIT‐HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double‐blind, placebo‐controlled study

European Journal of Heart Failure ◽

10.1002/ejhf.1452 ◽

2019 ◽

Vol 21 (5) ◽

pp. 676-684 ◽

Author(s):

Udo Bavendiek ◽

Dominik Berliner ◽

Lukas Aguirre Dávila ◽

Johannes Schwab ◽

Lars Maier ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Clinical consequences of angiotensin-converting enzyme inhibitor withdrawl in chronic heart failure: A double-blind, placebo-controlled study of quinapril

Journal of the American College of Cardiology ◽

10.1016/0735-1097(93)90578-o ◽

1993 ◽

Vol 22 (6) ◽

pp. 1557-1563 ◽

Author(s):

Peter W. Pflugfelder ◽

G. Baird ◽

Melvin J. Tonkon ◽

Robert DiBianco ◽

Bertram Pitt

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Angiotensin Converting Enzyme ◽

Angiotensin Converting Enzyme Inhibitor ◽

Enzyme Inhibitor ◽

Controlled Study ◽

Converting Enzyme ◽

Double Blind ◽

Double Blind Placebo ◽

Clinical Consequences

Download Full-text

A multi-center, randomized, double-blind, placebo-parallel controlled trial for the efficacy and safety of shenfuqiangxin pills in the treatment of chronic heart failure (Heart-Kidney yang deficiency syndrome)

Medicine ◽

10.1097/md.0000000000020271 ◽

2020 ◽

Vol 99 (21) ◽

pp. e20271 ◽

Author(s):

Lijun Guo ◽

Hui Yuan ◽

Dawu Zhang ◽

Jian Zhang ◽

Qi Hua ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Controlled Trial ◽

Deficiency Syndrome ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Kidney Yang Deficiency

Download Full-text

A multicenter, randomized, double-blind, controlled study to evaluate the efficacy and safety of dantrolene on ventricular arrhythmia as well as mortality and morbidity in patients with chronic heart failure (SHO-IN trial): rationale and design

Journal of Cardiology ◽

10.1016/j.jjcc.2019.08.020 ◽

2020 ◽

Vol 75 (4) ◽

pp. 454-461 ◽

Author(s):

Shigeki Kobayashi ◽

Takatoshi Wakeyama ◽

Shiro Ono ◽

Yasuhiro Ikeda ◽

Masato Omura ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Ventricular Arrhythmia ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Mortality And Morbidity

Download Full-text

Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Organic Nitrates in Patients With Chronic Heart Failure Treated With Angiotensin-Converting Enzyme Inhibition

Circulation ◽

10.1161/01.cir.99.20.2652 ◽

1999 ◽

Vol 99 (20) ◽

pp. 2652-2657 ◽

Author(s):

Uri Elkayam ◽

Janet V. Johnson ◽

Avraham Shotan ◽

Syed Bokhari ◽

Alejandro Solodky ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Angiotensin Converting Enzyme ◽

Controlled Study ◽

Angiotensin Converting Enzyme Inhibition ◽

Organic Nitrates ◽

Converting Enzyme ◽

Double Blind ◽

Double Blind Placebo ◽

Converting Enzyme Inhibition

Download Full-text

Efficacy and Safety of Tolvaptan in Heart Failure Patients with Volume Overload Despite the Standard Treatment with Conventional Diuretics: A Phase III, Randomized, Double-blind, Placebo-controlled Study (QUEST Study)

Cardiovascular Drugs and Therapy ◽

10.1007/s10557-011-6304-x ◽

2011 ◽

Vol 25 (S1) ◽

pp. 33-45 ◽

Author(s):

Masunori Matsuzaki ◽

◽

Masatsugu Hori ◽

Tohru Izumi ◽

Masatake Fukunami

Keyword(s):

Heart Failure ◽

Standard Treatment ◽

Volume Overload ◽

Phase Iii ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Heart Failure Patients

Download Full-text

Clinical Efficacy of Flosequinan in Patients with Mild Chronic Heart Failure: a Double-Blind Placebo-Controlled Study

New Aspects in the Treatment of Failing Heart ◽

10.1007/978-4-431-68219-6_27 ◽

1992 ◽

pp. 153-155

Author(s):

Katsuji Imai ◽

Masatsugu Hori ◽

Hideyuki Sato ◽

Hitoshi Ozaki ◽

Michitoshi Inoue ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Clinical Efficacy ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Long-term clinical effect of nilvadipine in patients with chronic heart failure: A double-blind placebo-controlled study

Heart and Vessels ◽

10.1007/bf01745105 ◽

1994 ◽

Vol 9 (5) ◽

pp. 249-253 ◽

Author(s):

Masatsugu Hori ◽

Hideyuki Sato ◽

Michiko Karita ◽

Kazuhisa Kodama ◽

Noritake Hoki ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Clinical Effect ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text